Considering that METTL3, a core RNA methyltransferase, can catalyze the formation of RNA m6A, we next evaluated whether celastrol treatment regulated the global levels of RNA m6A in pancreatic cancer cells by RNA m6A dot blot assay and quantification of RNA total m6A modification assay, respectively. This evidence concerns the gene METTL3 and pancreatic neoplasm.